Gene · 6375
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Graph Embedding Methods for Multiple-Omics Data Analysis. | Front Genet | 2021 | 34616440 | PubTator, text mining | PubMed |
| Tumor-Experienced Human NK Cells Express High Levels of PD-L1 and Inhibit CD8+ T Cell Proliferation. | Front Immunol | 2021 | 34616407 | PubTator, text mining | PubMed |
| Is there a role for neoadjuvant anti-PD-1 therapies in glioma? | Curr Opin Neurol | 2021 | 34608074 | PubTator, text mining | PubMed |
| Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma. | Front Oncol | 2021 | 34604068 | PubTator, text mining | PubMed |
| Graph Representation Forecasting of Patient's Medical Conditions: Toward a Digital Twin. | Front Genet | 2021 | 34603366 | PubTator, text mining | PubMed |
| The expression landscape of JAK1 and its potential as a biomarker for prognosis and immune infiltrates in NSCLC. | BMC Bioinformatics | 2021 | 34587898 | PubTator, text mining | PubMed |
| YEATS domain-containing 2 (YEATS2), targeted by microRNA miR-378a-5p, regulates growth and metastasis in head and neck squamous cell carcinoma. | Bioengineered | 2021 | 34587874 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma. | Mol Cancer | 2021 | 34583709 | PubTator, text mining | PubMed |
| Combination strategies to maximize the benefits of cancer immunotherapy. | J Hematol Oncol | 2021 | 34579759 | PubTator, text mining | PubMed |
| Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy. | Int J Mol Sci | 2021 | 34575965 | PubTator, text mining | PubMed |
| Cytokine and Chemokine Responses in Invasive Aspergillosis Following Hematopoietic Stem Cell Transplantation: Past Evidence for Future Therapy of Aspergillosis. | J Fungi (Basel) | 2021 | 34575791 | PubTator, text mining | PubMed |
| Natural killer cells and dendritic epidermal γδ T cells orchestrate type 1 conventional DC spatiotemporal repositioning toward CD8+ T cells. | iScience | 2021 | 34568787 | PubTator, text mining | PubMed |
| The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment. | Front Oncol | 2021 | 34568077 | PubTator, text mining | PubMed |
| P300/CBP-associated factor (PCAF)-mediated acetylation of Fascin at lysine 471 inhibits its actin-bundling activity and tumor metastasis in esophageal cancer. | Cancer Commun (Lond) | 2021 | 34555274 | PubTator, text mining | PubMed |
| Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients. | Signal Transduct Target Ther | 2021 | 34531370 | PubTator, text mining | PubMed |
| The Th1 cell regulatory circuitry is largely conserved between human and mouse. | Life Sci Alliance | 2021 | 34531288 | PubTator, text mining | PubMed |
| Understanding the pathogenesis of infectious diseases by single-cell RNA sequencing. | Microb Cell | 2021 | 34527720 | PubTator, text mining | PubMed |
| Screening and evaluation of the role of immune genes of brain metastasis in lung adenocarcinoma progression based on the TCGA and GEO databases. | J Thorac Dis | 2021 | 34527340 | PubTator, text mining | PubMed |
| Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma. | Immunity | 2021 | 34525340 | PubTator, text mining | PubMed |
| Neurotoxicity of a pyrethroid pesticide deltamethrin is associated with the imbalance in proteolytic systems caused by mitophagy activation and proteasome inhibition. | Toxicol Appl Pharmacol | 2021 | 34520793 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6375/papers?page=51